AcCELLerated Biologics Announces Exclusive Distribution Agreement
AcCELLerated Biologics, LLC has made a noteworthy move in the field of regenerative medicine technologies by announcing an exclusive agreement to distribute the RegenaLase™ Laser System throughout the United States. This collaboration with IPG Medical Corporation, a subsidiary of IPG Photonics Corporation, aims to enhance treatment options available to physicians for musculoskeletal conditions.
Innovative Features of the RegenaLase™ Laser System
The RegenaLase system offers a dual-wavelength laser platform designed to address various musculoskeletal soft tissue issues, including conditions affecting meniscus cartilage and inflammation. The two advanced laser modalities include:
1550 nm Erbium Fiber Laser
This specific laser modality is engineered for minimally invasive cartilage surgeries, making it an excellent choice for practitioners looking to perform delicate procedures with enhanced precision.
980 nm Diode Laser
This non-invasive modality is primarily used for photobiomodulation therapy, providing viable options for pain relief without the need for extensive surgical interventions.
With both modalities integrated into a single, compact device, the RegenaLase system allows physicians to offer pain relief and advanced cartilage treatment within a streamlined process.
Expert Opinions on the New Technology
Steve Whyte, the CEO and Founder of AcCELLerated Biologics, expressed his excitement about the partnership, stating, "This partnership marks a significant milestone in regenerative medicine. The RegenaLase system introduces innovative laser technology combined with non-invasive therapy, giving physicians effective tools to alleviate pain and restore cartilage without conventional surgical risks."
Industry specialists share similar sentiments regarding the potential of the RegenaLase system. Dr. Joshua G. Hackel, a Sports Medicine Specialist, emphasized the system's game-changing capabilities after participating in a recent training course. He is particularly enthusiastic about conducting a prospective study aimed at treating knee osteoarthritis using this advanced laser system.
Likewise, Dr. Michael A. Scarpone, a regenerative medicine expert, noted the positive impact that the RegenaLase laser could have on treating knee osteoarthritis, expressing eagerness to partake in ongoing research projects centered around this technology.
Clinical Effectiveness and Treatment Applications
Research has validated the efficacy of the RegenaLase system when utilized in combination with biologic adjuncts like Platelet-Rich Plasma (PRP) and bone marrow aspirate. Clinical trials have shown that patients experience considerable pain reduction and significant enhancements in joint function post-treatment.
A Versatile Solution for Healthcare Providers
The design of the RegenaLase system takes into account the need for ergonomic use in various medical settings. Whether in a surgical suite or an office environment, the system's flexibility caters to tailored treatment approaches. It efficiently delivers multiple, separated microscopic columns of coagulation directly to targeted tissues.
Commitment to Advancing Regenerative Medicine
Alexander Vybornov, IPG Medical's Senior Director of Partnerships & Commercialization, remarked on the importance of this collaboration. He stated, "By working with AcCELLerated Biologics, we can extend the reach of the RegenaLase system in the U.S. Our combined expertise in laser technologies and clinical support will enable more physicians to offer this groundbreaking therapy for pain management and the rehabilitation of musculoskeletal tissues."
Company Overview
AcCELLerated Biologics is recognized for its commitment to transformative advancements in regenerative medicine. The company specializes in distributing innovative medical technologies and biologics designed to enhance patient outcomes significantly.
Contacting AcCELLerated Biologics
For further inquiries about the RegenaLase system or to learn more about AcCELLerated Biologics, individuals can reach out through the following contact information:
Sharon Bruneau
Phone: +1 (407) 230-3290
Email: sharon@accelleratedbiologics.com
Frequently Asked Questions
What is the RegenaLase™ Laser System?
The RegenaLase™ Laser System is an innovative dual-wavelength laser platform designed for the treatment of musculoskeletal soft tissue issues, including cartilage repair.
What are the advantages of the dual-wavelength technology?
This technology offers both minimally invasive surgical options and non-invasive pain relief therapies, making it versatile for various treatment protocols.
How does the RegenaLase system improve patient outcomes?
Clinical studies indicate significant pain reduction and improved joint function when the laser is used alongside biologic treatments like PRP.
What is AcCELLerated Biologics' role in this partnership?
AcCELLerated Biologics serves as the distributor for the RegenaLase system, providing clinical support and enhancing accessibility for physicians throughout the U.S.
How can I get in touch with AcCELLerated Biologics?
You can contact Sharon Bruneau at +1 (407) 230-3290 or via email at sharon@accelleratedbiologics.com.
